French government considers involvement in Sanofi sale to secure jobs

The French government is currently considering options to acquire a state stake in Sanofi's healthcare division, which is on the verge of being sold to the U.S. investment firm Clayton Dubilier & Rice (CD&R). This move aims to secure jobs and production in France. CD&R is nearing the acquisition of a 50-percent majority stake in Sanofi's Opella unit, having outbid French competitor PAI Partners. The deal, valued at around 15 billion euros (16.4 billion dollars), includes the sale of over-the-counter medications. Among these is the painkiller Doliprane, considered the most commonly used medication in France.